Steven Y Wei, MD | |
11 Industrial Park Rd, Niantic, CT 06357-1210 | |
(860) 889-7345 | |
Not Available |
Full Name | Steven Y Wei |
---|---|
Gender | Male |
Speciality | Orthopedic Surgery |
Experience | 30 Years |
Location | 11 Industrial Park Rd, Niantic, Connecticut |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1225067895 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207X00000X | Orthopaedic Surgery | 040975 (Connecticut) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Lawrence & Memorial Hospital | New london, CT | Hospital |
William W Backus Hospital | Norwich, CT | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Norwich Orthopedic Group Pc | 6709820798 | 45 |
Ptsma Inc | 7911800180 | 92 |
News Archive
Impax Laboratories, Inc. today announced that it has entered into a product development and supply agreement with IGI Laboratories, Inc., a formulation and manufacturing company. IGI will be responsible for developing two topical drug products, obtaining FDA marketing approvals, and manufacturing the commercial products.
Patients receiving hormone therapy as part of their gender-transition treatment had an elevated risk for cardiovascular events, including strokes, heart attacks and blood clots, according to a study published in the American Heart Association's journal Circulation.
"Even in people who have gone through six or more previous courses of chemotherapy, cetuximab, may fight the growth of cancer, giving patients additional months of life," says study presenter Heinz-Josef Lenz, M.D., associate professor of medicine at the Keck School of Medicine of the University of Southern California and USC/Norris Comprehensive Cancer Center.
In a new report published today, ''Susceptibility of Plasmodium Falciparum to Antimalarial Drugs,'' the World Health Organization (WHO) warns that as more and more people gain access to these life-saving malaria medicines, which combine a drug derived from the plant Artemisia annua with a second, synthetic drug, it is vital that countries closely monitor their effectiveness.
› Verified 3 days ago
Entity Name | Norwich Orthopedic Group Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1558316919 PECOS PAC ID: 6709820798 Enrollment ID: O20050610000216 |
News Archive
Impax Laboratories, Inc. today announced that it has entered into a product development and supply agreement with IGI Laboratories, Inc., a formulation and manufacturing company. IGI will be responsible for developing two topical drug products, obtaining FDA marketing approvals, and manufacturing the commercial products.
Patients receiving hormone therapy as part of their gender-transition treatment had an elevated risk for cardiovascular events, including strokes, heart attacks and blood clots, according to a study published in the American Heart Association's journal Circulation.
"Even in people who have gone through six or more previous courses of chemotherapy, cetuximab, may fight the growth of cancer, giving patients additional months of life," says study presenter Heinz-Josef Lenz, M.D., associate professor of medicine at the Keck School of Medicine of the University of Southern California and USC/Norris Comprehensive Cancer Center.
In a new report published today, ''Susceptibility of Plasmodium Falciparum to Antimalarial Drugs,'' the World Health Organization (WHO) warns that as more and more people gain access to these life-saving malaria medicines, which combine a drug derived from the plant Artemisia annua with a second, synthetic drug, it is vital that countries closely monitor their effectiveness.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Steven Y Wei, MD 82 New Park Ave, North Franklin, CT 06254-1807 Ph: (860) 889-7345 | Steven Y Wei, MD 11 Industrial Park Rd, Niantic, CT 06357-1210 Ph: (860) 889-7345 |
News Archive
Impax Laboratories, Inc. today announced that it has entered into a product development and supply agreement with IGI Laboratories, Inc., a formulation and manufacturing company. IGI will be responsible for developing two topical drug products, obtaining FDA marketing approvals, and manufacturing the commercial products.
Patients receiving hormone therapy as part of their gender-transition treatment had an elevated risk for cardiovascular events, including strokes, heart attacks and blood clots, according to a study published in the American Heart Association's journal Circulation.
"Even in people who have gone through six or more previous courses of chemotherapy, cetuximab, may fight the growth of cancer, giving patients additional months of life," says study presenter Heinz-Josef Lenz, M.D., associate professor of medicine at the Keck School of Medicine of the University of Southern California and USC/Norris Comprehensive Cancer Center.
In a new report published today, ''Susceptibility of Plasmodium Falciparum to Antimalarial Drugs,'' the World Health Organization (WHO) warns that as more and more people gain access to these life-saving malaria medicines, which combine a drug derived from the plant Artemisia annua with a second, synthetic drug, it is vital that countries closely monitor their effectiveness.
› Verified 3 days ago
Richard Justin Thoms, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 11 Industrial Park Rd, Niantic, CT 06357 Phone: 860-889-7345 | |
Dr. Jonathan Robert Piposar, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 11 Industrial Park Road, Niantic, CT 06357 Phone: 860-889-7345 | |
Dr. Emily Claire Vafek, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 11 Industrial Park Road, Niantic, CT 06357 Phone: 860-889-7345 | |
Dr. Anthony S. D. Parisi, M. D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 24 Billow Rd, Niantic, CT 06357 Phone: 860-691-0642 |